We are a global biotechnology company specialized in the development, production, and marketing of products and services for animal health, productivity, and well-being.
We are present in 60 countries in the Americas, Asia, Europe, the Middle East, North Africa, and Oceania, where we seek to collaborate in strengthening the health status of each country, promoting new productive developments, and ensuring animal, human, and ecosystem well-being.
We are a team of +1300 collaborators worldwide, with a modern management that integrates multiple nationalities. We are supported by our background and constant evolution.
We are driven by an inquisitive spirit in the pursuit of anticipating and thinking innovative solutions for animal health issues, through different business models.
At Biogénesis Bagó, we support producers, veterinarians, health authorities, and society in general, helping to address the challenges we face as human beings: addressing antimicrobial resistance, making livestock and food production more efficient and sustainable, reducing losses associated with diseases, and consolidating more competitive and resilient markets through disease prevention, diagnosis, and treatment.
We provide solutions primarily for disease prevention, control, treatment, and eradication.
We work in line with the "One Health" concept, which establishes that "human and animal health are interdependent and linked to the ecosystems in which they coexist."
Through our products for animal and environmental health, we generate added value for the production of safe food and also contribute to human health.
We are continuously working on prevention programs through the use of safe, effective, and quality vaccines, thus providing health to all species we focus on.
We are a global leader in foot-and-mouth disease vaccines, the main supplier of canine rabies vaccine to the Pan American Health Organization, and since becoming a member of its Revolving Fund in 2012, we have supplied more than 140 million doses of rabies vaccine to 15 countries, and are on track to become the largest producer of veterinary vaccines in Latin America.